Bausch Health Companies Inc. Common Stock (BHC)

R&D Expense Growth

6.13%

Quarterly · Period ending:

BHC logo

BHC R&D Expense Growth

Latest reported6.13%
BHC Quarterly R&D Growth (QoQ) (0.00% → 6.13%)
High-resolution chart · PNG

BHC r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bausch Health Companies Inc. Common Stock R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
6.135%
219.6078%
-79.3522%
55.3459%
11.1888%
-12.2699%
1.2422%
1.2579%
5.298%
-0.6579%
-0.6536%
-1.9231%
9.0909%
0.7042%
6.7669%
3.9063%
0.7874%
4.0984%
0.8264%
4.3103%
1.7544%
-13.6364%
14.7826%
0%
-6.5041%
-18%
20.9677%
0%
5.0847%
-2.4793%
13.0841%
13.8298%
1.0753%
3.3333%
11.1111%
-14.7368%
-5%
7.5269%
-29.5455%
4.7619%
21.1538%
-48.3871%
98.3268%
25.2774%
45.3405%
-5.5838%
0%
-21.0948%
2.1828%
33.5155%
-68.2659%
606.1224%
2.9412%
18.0263%
-87.7394%
638.2288%
1.2406%
-81.9589%
597.9686%
-1.6213%
13.3631%
-59.9366%
173.5557%
-61.6243%
-44.2971%
74.3574%
65.3392%
-48.0847%
207.6267%
-9.6798%
-13.8365%
-14.2056%
-40.1106%
24.1101%
-4.5641%
7.8286%
-4.2898%
4.677%
7.7571%
43.191%
-17.5833%
-16.5277%
34.3293%
-12.478%
11.0558%
-2.5867%
19.1693%
11.4845%
-12.0116%
-31.1823%
26.8585%
-5.5242%
21.143%
42.8707%
-13.8315%
1.197%
38.0684%
-26.0421%
17.7733%
-13.6204%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.